Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 127

1.

Histological analysis of the skin of Abca1-deleted mice: A potential model for dry skin.

Deng Y, Ohgami N, Iida M, Tazaki A, Intoh A, Kondo-Ida L, Lu R, Tsuzuki T, Yokoyama S, Kato M.

Eur J Dermatol. 2019 Oct 1;29(5):549-551. doi: 10.1684/ejd.2019.3621. No abstract available.

PMID:
31789279
2.

Low ankle brachial index predicts poor outcomes including target lesion revascularization during the long-term follow up after drug-eluting stent implantation for coronary artery disease.

Sasaki M, Mitsutake Y, Ueno T, Fukami A, Sasaki KI, Yokoyama S, Ohtsuka M, Nakayoshi T, Itaya N, Chibana H, Sasaki M, Ishimatsu T, Kagiyama K, Fukumoto Y.

J Cardiol. 2019 Aug 24. pii: S0914-5087(19)30241-2. doi: 10.1016/j.jjcc.2019.07.015. [Epub ahead of print]

PMID:
31455545
3.

Selective Correction of Genotype Yield by Probucol in HDL-Deficient Mice Propagation.

Tsujita M, Akita N, Yokota T, Kobayashi F, Yokoyama S.

J Atheroscler Thromb. 2019 May 14. doi: 10.5551/jat.48967. [Epub ahead of print]

4.

Oxidation of methionine residues in human apolipoprotein A-I generates a potent pro-inflammatory molecule.

Witkowski A, Carta S, Lu R, Yokoyama S, Rubartelli A, Cavigiolio G.

J Biol Chem. 2019 Mar 8;294(10):3634-3646. doi: 10.1074/jbc.RA118.005663. Epub 2019 Jan 11.

PMID:
30635405
5.

Application of the Japanese Guidelines for the Diagnosis of Familial Hypercholesterolemia in General Practice: It is to be Validated in International Harmonization.

Tanaka N, Teramoto T, Yokoyama S.

J Atheroscler Thromb. 2019 Jan 1;26(1):93-98. doi: 10.5551/jat.46979. Epub 2018 Nov 27. No abstract available.

6.

Beneficial Effect of Retuning to "Japan Diet" for the Japanese.

Yokoyama S.

J Atheroscler Thromb. 2019 Jan 1;26(1):1-2. doi: 10.5551/jat.ED099. Epub 2018 Jun 2. No abstract available.

7.

Trend of HDL increase among Japanese people continues in National Health and Nutrition Survey.

Yokoyama S.

J Atheroscler Thromb. 2018 Jun 1;25(6):554-556. doi: 10.5551/jat.43646. Epub 2018 Feb 2. No abstract available.

8.

What does Commercial Database Tell us About Medical Sciences?

Yokoyama S.

J Atheroscler Thromb. 2018 Jul 4;25(7):568-569. doi: 10.5551/jat.ED090. Epub 2018 Jan 26. No abstract available.

9.

ApoA-I/A-II-HDL positively associates with apoB-lipoproteins as a potential atherogenic indicator.

Kido T, Kondo K, Kurata H, Fujiwara Y, Urata T, Itakura H, Yokoyama S.

Lipids Health Dis. 2017 Nov 29;16(1):225. doi: 10.1186/s12944-017-0619-y.

10.

Pulmonary artery dysfunction in chronic thromboembolic pulmonary hypertension.

Chibana H, Tahara N, Itaya N, Ishimatsu T, Sasaki M, Sasaki M, Nakayoshi T, Ohtsuka M, Yokoyama S, Sasaki KI, Ueno T, Fukumoto Y.

Int J Cardiol Heart Vasc. 2017 Nov 9;17:30-32. doi: 10.1016/j.ijcha.2017.09.001. eCollection 2017 Dec.

11.

AGE-albumin enhances ABCA1 degradation by ubiquitin-proteasome and lysosomal pathways in macrophages.

Iborra RT, Machado-Lima A, Okuda LS, Pinto PR, Nakandakare ER, Machado UF, Correa-Giannella ML, Pickford R, Woods T, Brimble MA, Rye KA, Lu R, Yokoyama S, Passarelli M.

J Diabetes Complications. 2018 Jan;32(1):1-10. doi: 10.1016/j.jdiacomp.2017.09.012. Epub 2017 Sep 23.

PMID:
29097054
12.

Exposure to High Glucose Concentration Decreases Cell Surface ABCA1 and HDL Biogenesis in Hepatocytes.

Tsujita M, Hossain MA, Lu R, Tsuboi T, Okumura-Noji K, Yokoyama S.

J Atheroscler Thromb. 2017 Nov 1;24(11):1132-1149. doi: 10.5551/jat.39156. Epub 2017 Apr 19.

13.

Homogeneous Assays for LDL-C and HDL-C are Reliable in Both the Postprandial and Fasting State.

Miida T, Nishimura K, Hirayama S, Miyamoto Y, Nakamura M, Masuda D, Yamashita S, Ushiyama M, Komori T, Fujita N, Yokoyama S, Teramoto T.

J Atheroscler Thromb. 2017 Jun 1;24(6):583-599. doi: 10.5551/jat.40006. Epub 2017 Mar 17.

14.

Methods for Monitoring ABCA1-Dependent Sterol Release.

Yamauchi Y, Yokoyama S, Chang TY.

Methods Mol Biol. 2017;1583:257-273. doi: 10.1007/978-1-4939-6875-6_19.

15.

Interleukin-1β is associated with coronary endothelial dysfunction in patients with mTOR-inhibitor-eluting stent implantation.

Chibana H, Kajimoto H, Ueno T, Yokoyama S, Sasaki KI, Ohtsuka M, Koiwaya H, Nakayoshi T, Mitsutake Y, Itaya N, Sasaki M, Fukumoto Y.

Heart Vessels. 2017 Jul;32(7):823-832. doi: 10.1007/s00380-017-0947-x. Epub 2017 Jan 23.

PMID:
28116487
16.

Caveolin-1 facilitates internalization and degradation of ABCA1 and probucol oxidative products interfere with this reaction to increase HDL biogenesis.

Lu R, Tsuboi T, Okumura-Noji K, Iwamoto N, Yokoyama S.

Atherosclerosis. 2016 Oct;253:54-60. doi: 10.1016/j.atherosclerosis.2016.08.025. Epub 2016 Aug 24.

PMID:
27579791
17.

Differential angioscopic findings of neointimal coverage among first-, second-, and next generation drug-eluting stents.

Nakayoshi T, Ueno T, Sasaki KI, Yokoyama S, Ohtsuka M, Mitsutake Y, Itaya N, Chibana H, Sasaki M, Ishimatsu T, Kimura T, Fukumoto Y.

Int J Cardiol. 2016 Nov 15;223:450-451. doi: 10.1016/j.ijcard.2016.08.175. Epub 2016 Aug 9. No abstract available.

PMID:
27544603
18.

Bioinformatic Analysis of Plasma Apolipoproteins A-I and A-II Revealed Unique Features of A-I/A-II HDL Particles in Human Plasma.

Kido T, Kurata H, Kondo K, Itakura H, Okazaki M, Urata T, Yokoyama S.

Sci Rep. 2016 Aug 16;6:31532. doi: 10.1038/srep31532.

19.

Clinical equivalency of cardiopulmonary bypass and extracorporeal membrane oxygenation support for pediatric tracheal reconstruction.

Hasegawa T, Oshima Y, Matsuhisa H, Okata Y, Yokoi A, Yokoyama S, Maeda K.

Pediatr Surg Int. 2016 Nov;32(11):1029-1036. Epub 2016 Jun 25.

PMID:
27344586
20.

Supplemental Content

Loading ...
Support Center